Farsiani Fatemeh, Tayebi Pouya, Parsa Maryam, Bijani Ali, Nabipour Majid, Moslemi Dariush
Department of Vascular and Endovascular Surgery, Rouhani Hospital, Babol University of Medical Sciences, Keshavarz Boulevard, Babol, 4717647745 Mazandaran Iran.
Social Determinant of Health Research Center, Babol University of Medical Sciences, Babol, Iran.
Indian J Surg Oncol. 2025 Feb;16(1):344-348. doi: 10.1007/s13193-024-02095-6. Epub 2024 Sep 20.
Breast cancer, the most prevalent malignancy in women, has witnessed an increased incidence alongside the rising use of port catheters and chemotherapy. Despite the conventional practice of contralateral port placement, the impact of side selection on complications remains unclear, necessitating a nuanced investigation. This prospective cross-sectional study, conducted from 2021 to 2022, involved 100 females over 18 undergoing port catheter placements for breast cancer. Meticulous data collection included patient demographics, procedure details, and postoperative complications. Statistical analyses were employed to assess variables, and ethical principles were followed. Findings revealed no statistically significant differences in complication rates between ipsilateral and contralateral placements. The absence of infections, fractures, thrombosis, or catheter displacement underscored overall safety. Intriguingly, no discernible impact on breast cancer subtype distribution was observed, challenging conventional assumptions. This investigation into the laterality of port catheter placement in breast cancer patients yielded promising outcomes. The absence of significant complications and the negligible impact on cancer subtype distribution underscore the safety and efficacy of this intervention. However, individual patient characteristics and procedural nuances should guide decisions about port catheter placement, contributing valuable insights to optimize strategies for improved patient outcomes.
乳腺癌是女性中最常见的恶性肿瘤,随着输液港导管和化疗使用的增加,其发病率也在上升。尽管传统做法是在对侧放置输液港,但选择放置侧对并发症的影响仍不明确,因此需要进行细致的调查。这项前瞻性横断面研究于2021年至2022年进行,纳入了100名18岁以上因乳腺癌接受输液港导管置入术的女性。精心收集的数据包括患者人口统计学信息、手术细节和术后并发症。采用统计分析来评估变量,并遵循伦理原则。研究结果显示,同侧和对侧放置的并发症发生率在统计学上没有显著差异。未出现感染、骨折、血栓形成或导管移位,总体安全性良好。有趣的是,未观察到对乳腺癌亚型分布有明显影响,这对传统假设提出了挑战。这项对乳腺癌患者输液港导管放置侧性的调查取得了有前景的结果。没有明显并发症且对癌症亚型分布影响可忽略不计,这突出了该干预措施的安全性和有效性。然而,应根据个体患者特征和手术细节来指导输液港导管放置的决策,为优化策略以改善患者预后提供有价值的见解。